Mark Lively became the 94th president of the Federation of American Societies for Experimental Biology on July 1.
Also, William Talman, a professor of neurology and neuroscience at the University of Iowa, was voted FASEB's president-elect.
Lively is a professor of biochemistry at Wake Forest University, where is he is also director of the Molecular Genetics Program and director of the Biomolecular Resource Laboratory. His presidency at FASEB is for one year.
FASEB is a coalition of 22-member societies comprising more than 90,000 biomedical researchers. Lively was appointed to the FASEB board in 2004 as a representative for the Association of Biomolecular Resource Facilities. He was ABRF's president from 2001 to 2002.
Pronota last week said that Ruth Devenyns has joined its board.
Devenyns is an investment director at KBC Private Equity, an investor in Pronota. KBC participated in the recent €4.9 million first close of Series B financing by Pronota [see accompanying story this issue].